Part-Time

Pharmacy Technician

Deadline 9/23/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$18.94 - $28.94/hr

Company Historically Provides H1B Sponsorship

Canton, CT, USA

In Person

May require voluntary travel to other stores in the market for shifts.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Customer Service

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • Comply with state board of pharmacy requirements and laws governing the practice of pharmacy, including applicable age, education, and licensure or certification requirements.
  • If the state board of pharmacy does not mandate a minimum age, be at least 16 years of age.
  • If the state board of pharmacy does not mandate a minimum educational requirement, have a high school diploma or equivalent, or be actively enrolled in high school or a high school equivalency program.
  • Meet applicable state-level licensure and national certification requirements.
  • Complete required training within the designated timeframe.
  • Maintain regular and predictable attendance, including nights and weekends.
  • Concentrate on tasks, pivot quickly between tasks, and confirm prescription information and label accuracy.
  • Use verbal and written communication and active listening to interact with patients and colleagues.
  • Use mathematical reasoning to determine tablet quantities, days' supply, and bottle quantities for prescriptions.
  • Identify challenging patient or colleague interactions and choose an appropriate response.
  • Remain mobile and upright for extended periods; lift, scan, bag, reach, stoop, type, and perform repetitive hand and arm movements as required.
  • Lift up to 20 pounds occasionally and up to 10 pounds frequently.
  • Accurately receive and convey detailed information through spoken communication.
Responsibilities
  • Follow company standard operating procedures at each workstation to help pharmacists manage and improve patient health.
  • Follow pharmacy workflow procedures in production, pick-up, drive-thru, and drop-off areas for safe and accurate prescription fulfillment.
  • Provide empathetic and caring service to patients at pick-up, drive-thru, and over the phone; offer immunizations and other services where permitted; and solve or escalate patient problems.
  • Complete basic inventory activities, including putting away medication deliveries, cycle counts, returns-to-stocks, and waiting-bin inventories, as permitted by law and directed by pharmacy leadership.
  • Remain flexible for scheduling and business needs and travel voluntarily to other stores in the market for shifts as needed.
  • Comply with federal, state, and local laws, regulations, professional standards, ethical principles, and company policies, including controlled-substance dispensing and recordkeeping and patient privacy and security requirements.
  • Deliver additional patient health care services, such as immunizations, point-of-care testing, and staffing offsite clinics, where permitted by law and supported by required training and certification.
  • Complete additional licensure and training requirements to obtain Technician Immunizer status where permitted.
  • Educate patients about the importance of vaccines and refer vaccination questions to the pharmacist on duty.
  • Monitor and respond to adverse vaccine reactions and report adverse-reaction events as required.
  • Review and collect patient information and track and document information for applicable patients.
  • Monitor and manage vaccine supplies.
  • Perform additional tasks as directed by a supervisor or manager.
Desired Qualifications
  • One to three years of previous experience as a Pharmacy Technician.
  • Previous experience in a pharmacy, retail, medical, or customer service setting.
  • Ability to work in the home store and across the market in other locations to meet business needs.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 guidance rose to $7.90-$8.10, with revenue at least $414 billion.
  • Q2 2026 revenue hit $106.1 billion, and all three segments beat estimates.
  • Omnicare's 2026 sale and Aetna margin recovery free capital for core businesses.

What critics are saying

  • March 11, 2026 Aetna settled Medicare fraud claims for $117.7 million.
  • March 24, 2026 FTC settlement talks over insulin pricing keep Caremark under fire.
  • If PBM rules tighten in 2026, Caremark loses pricing power and CVS's earnings engine.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies into one consumer funnel.
  • The August 5, 2026 Eli Lilly app deal links insurance, retail, and obesity care.
  • Its pharmacy-focused Houston format expands access while defending local prescription traffic.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.

PR Newswire
Aug 5th, 2026
CVS Health posts $106.1B Q2 revenue, raises full-year earnings guidance to $7.90-$8.10

CVS Health reported second quarter 2026 revenues of $106.1 billion, up 7.3% year-over-year. The company posted GAAP diluted earnings per share of $2.31 and adjusted EPS of $2.58, compared to $0.80 and $1.81 respectively in the prior year. The company raised its full-year 2026 guidance, increasing GAAP diluted EPS guidance to $6.84-$7.04 from $6.24-$6.44 and adjusted EPS guidance to $7.90-$8.10 from $7.30-$7.50. Cash flow from operations guidance was raised to at least $11.5 billion from at least $9.5 billion. CVS Health generated $10.6 billion in year-to-date cash flow from operations. The improved performance was primarily driven by the Health Care Benefits segment, reflecting continued execution on its margin recovery plan. The company operates approximately 9,000 retail pharmacy locations and serves around 87 million plan members through its pharmacy benefits manager.

Yahoo Finance
Jul 24th, 2026
CVS's $7.8B free cash flow covers $2.66 dividend twice despite frozen payout and $175B debt load

CVS Health closed at $106.89 on 23 July 2026, up 78.2% over the past year. The company pays a quarterly dividend of $0.665, or $2.66 annually, yielding roughly 2.5%. The payout has remained frozen for 10 consecutive quarters, though CVS has never cut its dividend in 27 years. Free cash flow of $7.8 billion covers the dividend more than twice. Q1 2026 marked the fifth straight earnings beat, with adjusted EPS of $2.57 topping consensus by 16%. Revenue reached $100.43 billion, up 6.2% year over year. Risks include a leveraged balance sheet with $175 billion in liabilities and $3.12 billion in annual interest expense. CVS absorbed a $5.7 billion goodwill impairment in FY 2025 and posted a $3.2 billion operating loss in Q3 2025. Insiders sold $323.7 million worth of shares over the past three months.

Yahoo Finance
Jul 20th, 2026
Cloudflare and Rocket Lab attract investors while CVS Health faces growth headwinds

Two large-cap stocks show strong growth potential whilst one faces headwinds, according to StockStory analysis. CVS Health, with a market capitalisation of $137.1 billion, struggles with slowing growth. Its revenue increased just 6.3% annually over two years, underperforming peers. Wall Street expects flat revenue over the next 12 months. Earnings per share fell 1.5% annually over five years despite revenue growth. The stock trades at $107.70, or 13.9 times forward price-to-earnings. Cloudflare emerges as a buy candidate. The network security provider posted average billings growth of 34.2% over the past year. Analysts project 28.4% revenue growth for the coming year. The company trades at $276.18 per share, or 32.1 times forward price-to-sales. Rocket Lab also features on the buy list. The small satellite launch provider has reached a market capitalisation of $40.45 billion.